• Users Online: 343
  • Print this page
  • Email this page
Year : 2023  |  Volume : 3  |  Issue : 1  |  Page : 5-12

Newer therapeutic options in chronic obstructive pulmonary disease

Department of Pulmonary Medicine, Karuna Medical College, Palakkad, Kerala, India

Correspondence Address:
Dr. Jesin Kumar Chakkamadathil
Shivam, Guruvayur Road, Punkunnam, Thrissur - 680 002, Kerala
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jalh.jalh_23_22

Rights and Permissions

Chronic respiratory diseases, particularly chronic obstructive pulmonary disease (COPD), are the third leading cause of death worldwide behind only cardiovascular deaths (ischemic heart disease and stroke) and cancers. The issues of misdiagnosis and suboptimal management in COPD are evident from the global disease burden and disability-adjusted life years due to COPD. One of the many reasons for this could be a lack of awareness of the newer treatment modalities among the treating physicians. The recent years have seen the introduction of many new molecules for the treatment of COPD. Many of these drugs are extremely potent bronchodilators which, when used, can reduce overreliance on inhaled corticosteroids (ICSs). On the contrary, we need not refrain from the use of ICS particularly in cases where they are indicated. Targeted therapy of COPD is also coming up in a big way and is a sphere of medicine to watch out for in the future. Through this review, an attempt is made to summarize some of these recent advances in management of COPD.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded148    
    Comments [Add]    

Recommend this journal